Genetic susceptibility to advanced retinopathy of prematurity (ROP)

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Shastry, Barkur S ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; VASCULOTROPIN; WNT PROTEIN; EYE PROTEIN; FRIZZLED PROTEIN; FZD4 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE PROTEIN; NDP PROTEIN, HUMAN; NERVE PROTEIN; TSPAN12 PROTEIN, HUMAN;

BLINDNESS; CHILDHOOD DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EXPERIMENTAL STUDY; FAMILIAL EXUDATIVE VITREORETINOPATHY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; HYPOXIA; LIGHT EXPOSURE; LOW BIRTH WEIGHT; MONOZYGOTIC TWINS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SMALL FOR DATE INFANT; STRUCTURAL BIOINFORMATICS; STRUCTURAL GENOMICS; STRUCTURAL PROTEOMICS; VITREORETINOPATHY; VITREOUS BODY; GENETICS; METABOLISM; NEWBORN; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

EYE PROTEINS; FRIZZLED RECEPTORS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LDL-RECEPTOR RELATED PROTEINS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RETINOPATHY OF PREMATURITY; RISK FACTORS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 77955794752     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-69     Document Type: Review

References (49)

1. Molecular genetics of Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. BS Shastry, In retinal degeneration: causes, diagnosis and treatment New York: Nova Science Publishers Inc, Catlin RB, 2009 89 106
2. The incidence and course of retinopathy of prematurity: finding from the early treatment for retinopathy of prematurity study. WV Good RJ Hardy V Dobson EA Plamer DL Phelps M Quintos B Tung, Pediatrics 2005 116 15 23 10.1542/peds.2004-1413 15995025
3. Late - onset retinal detachment associated with regressed retinopathy of prematurity. H Terasaki T Hirose, Jpn J Ophthalmol 2003 47 492 497 10.1016/S0021-5155(03)00088-1 12967866
4. Partial retinal detachment at 3 months after threshold retinopathy of prematurity. WS Gilbert GE Quinn V Dobson J Reynolds RJ Hard EA Palmer, Arch Ophthalmol 1996 114 1085 1091 8790093
5. Retinopathy of prematurity. H Mechoulam EA Pierce, Am J Pharmacogenomics 2003 3 261 277 10.2165/00129785-200303040-00004 12930159
6. Retinopathy of prematurity: recent advances in our understanding. CM Wheatley JL Dickinson DA Mackey JE Craig MM Sale, Br J Ophthalmol 2002 86 696 701 10.1136/bjo.86.6.696 12034695
7. SNPs: impact on gene function and phenotype. BS Shastry, Methods Mol Biol 2009 578 3 22 full-text 19768584
8. Next generation sequencing of a 40 Mb linkage interval reveals TSPAN 12 mutations in patients with familial exudative vitreoretinopathy. K Nikopoulos C Gilissen A Hoischen CE van Nouhuys FN Boonstra EA Blokland P Arts N Wieskamp TM Strom C Ayuso MA Tilanus S Bouwhuis A Mukhopadhyay H Scheffer LH Hoefsloot JA Veltman FP Cremers RW Collin, Am J Hum Genet 2010 86 240 247 10.1016/j.ajhg.2009.12.016 20159111
9. Mutations in TSPAN 12 cause autosomal dominant familial exudative vitreoretinopathy. JA Poulter M Ali DF Gilmour A Rice H Kondo K Hayashi DA Mackey LS Kearns JB Ruddle JE Craig EA Pierce LM Downey MD Mohamed AF Markham CF Inglehearn C Toomes, Am J Hum Genet 2010 86 248 253 10.1016/j.ajhg.2010.01.012 20159112
10. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. BS Shastry D Pendergast MK Hartzer X Liu MT Trese, Arch Ophthalmol 1997 115 651 656 9152134
11. Mutations in the NDP gene: contribution to Norrie disease, Familial Exudative Vitreoretinopathy and Retinopathy of Prematurity. JL Dickinson MM Sale A Passmore LM FitzGerald CM Wheatley KP Burdon JE Craig S Tengtrisorn SM Carden H Maclean DA Mackey, Clin Exp Ophthalmol 2006 34 682 688 10.1111/j.1442-9071. 2006.01314.x
12. Vitreoretinal findings similar to retinopathy of prematurity in infants with compound heterozygous protein S deficiency. HA Mintz-Hittner MJ Miyashiro KM Knight-Nanan RE O'Malley RA Marlar, Ophthalmol 1999 106 1525 1530 10.1016/S0161-6420(99)90448-7
13. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. M Hiraoka DM Beristein MT Trese BS Shastry, J Hum Genet 2001 46 178 181 10.1007/s100380170085 11322656
14. De novo mutation in the 5'-regulatory region of the Norrie disease gene in retinopathy of prematurity. SJ Talks N Ebenezer P Hykin G Adams F Yang E Schulenberg K Gregory-Evans Y Gregory-Evans, J Med Genet 2001 38 46 10.1136/jmg.38.12.e46 11748312
15. C597A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in Kuwaiti infants. MZ Haider LV Devarajan M Al-Essa HA Kumar, J Biomed Sci 2002 9 365 370 12145535
16. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Kuwaiti children with retinopathy of prematurity. MZ Haider LV Devarajan M Al-Essa H Kumar, Biol Neonate 2002 82 84 88 10.1159/000063092 12169829
17. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. KA Hutcheson PC Paluru SL Bernstein J Koh EF Rappaport RA Leach TL Young, Mol Vis 2005 11 501 508 16052165
18. Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity. MLE MacDonald YP Goldberg J MacFarlane ME Samuels MT Trese BS Shastry, Clin Genet 2005 67 363 366 10.1111/j.1399-0004.2005.00408.x 15733276
19. Severe retinopathy of prematurity associated with FZD4 mutations. A Ells DL Guemsey K Wallace B Zheng M Vincer A Allen A Ingram O Da Silva L Siebert T Sheidow J Beis JM Robitaille, Ophthalmic Genet 2010 31 37 43 10.3109/13816810903479834 20141357
20. Genetic susceptibility to retinopathy of prematurity. MJ Bizzarro N Hussain B Jonsson R Feng LR Ment JR Gruen H Zhang V Bhandari, Pediatrics 2006 118 1858 1863 10.1542/peds.2006-1088 17079555
21. Is specific race a retinopathy prematurity risk factor. DM Lang J Backledege RW Arnold, Arch Pediatr Adolesc Med 2005 159 771 773 10.1001/archpedi.159.8.771 16061786
22. Difference between rat strains in models of retinopathy of prematurity. BN Floyd DA Leske SM Wren M Mookadam MP Fautsch JM Holmes, Mol Vis 2005 11 524 530 16052168
23. Strain-dependent differences in oxygen induced retinopathy of prematurity in the inbred rats. P Van Wijngaarden DJ Coster HM Brereton IL Gibbins KA Williams, Invest Ophthalmol Vis Sci 2005 46 1445 1452 10.1167/iovs.04-0708 15790914
24. Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. G Holmstrom P Van Wijngaarden DJ Coster KA Williams, Br J Ophthalmol 2007 97 1704 1708 10.1136/bjo.2007.117283
25. Regulation of Vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. EA Pierce ED Foley LEH Smith, Arch Ophthalmol 1996 114 1219 1228 8859081
26. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. T Alon I Hemo A Itin J Peer J Stone E Keshet, Nat Med 1995 1 1024 1028 10.1038/nm1095-1024 7489357
27. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity. SJ Budd ME Hartnett, Arch Ophthalmol 2010 128 589 595 10.1001/archophthalmol.2010. 65 20457980
28. Identification of polymorphisms within the vascular endothelial growth factor gene (VEGF): correlation with variation in VEGF protein production. CJ Watson NJ Webb MJ Bottomley PE Brenchley, Cytokine 2000 12 1232 1235 10.1006/cyto.2000.0692 10930302
29. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. W Renner S Kotschan C Hoffmann B Obermayer-Pietsch E Pilger, J Vas Res 2000 37 443 448 10.1159/000054076
30. Genetic polymorphisms and retinopathy of prematurity. RW Cooke JA Drury R Mountford D Clark, Invest Ophthalmol Vis Sci 2004 45 1712 1715 10.1167/iovs.03-1303 15161830
31. Association of genetic polymorphisms of vascular endothelial growth factor and risk of proliferative retinopathy of prematurity. AV Vannay G Dunai I Banyasz M Szabo R Vamos A Treszl J Hajdu T Tulassay YI Vasarhel, Pediatr Res 2005 57 396 398 10.1203/01.PDR.0000153867.80238.E0 15635051
32. Lack of association of the VEGF gene promoter (-634 G to C and -460 C to T) polymorphism and the risk of advanced retinopathy of prematurity. BS Shastry X Qu, Graefes Arch Clin Exp Ophthalmol 2007 245 741 743 10.1007/s00417-006-0480- 6 17119993
33. Lack of association of VEGF (-2578 C to A) and ANG2 (-35 G to C) gene polymorphisms with the progression of retinopathy of prematurity. BS Shastry, Graefes Arch Clin Exp Ophthalmol 2009 247 859 860 10.1007/s00417-008-0988-z 19018553
34. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. P Kwinta M Bik-Multanowski Z Mitkowska T Tomasik JJ Pietrzyk, Graefes Arch Clin Exp Ophthalmol 2008 246 1467 1475 10.1007/s00417-008-0865-9 18546007
35. Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. I Banyasz G Bokodl A Vannay B Szebenl A Treszl B Vasarhelyi T Tulassay A Szabo, Curr Eye Res 2006 31 685 690 10.1080/02713680600801123 16877277
36. Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity. G Dunai B Vasarhelyi M Szabo J Hajdu G Meszaros T Tulassay A Treszl, Curr Eye Res 2008 33 501 505 10.1080/02713680802018427 18568888
37. Postnatal serum insulin-like growth factor - I deficiency is associated with retinopathy of prematurity and other complications of premature birth. A Hellstrom E Engstrom AL Hard K Albertsson-Wildand B Carlsson A Niklasson C Lofqvist E Svensson S Holm U Ewald G Holmstrom LE Smith, Pediatrics 2003 112 1016 1020 10.1542/peds.112.5.1016 14595040
38. Assessment of the contribution of insulin-like growth factor -I receptor 3174 G to A polymorphism to the progression of advanced retinopathy of prematurity. BS Shastry, Eur J Ophthalmol 2007 17 950 953 18050122
39. Lack of association between insulin-like growth factor - I receptor G3174A polymorphism and retinoapthy of prematurity. A Balogh L Derzbach A Vannay B Vasarhelyi, Graefes Arch Clin Exp Ophthalmol 2006 244 1035 1038 10.1007/s00417-005-0203-4 16362313
40. Polymorphism in the renin-angiotensin system and outcome of very low birth weight infants. J Spiegler A Gilhaus IR Konig E Kattner M Vochem H Kuster J Moller D Muller A Kribs H Segerer C Weig W Nikischin A Van der Wense C Gebauer E Herting W Gopel, Neonatology 2009 97 10 14 10.1159/000226602 19571582
41. Angiotensin converting enzyme insertion/deletion polymorphism does not alter sepsis outcome in ventilated very low birth weight infants. BR John J Loggins K Yanamandra, J Perinatol 2005 25 205 209 10.1038/sj.jp.7211231 15549142
42. Genetic contributions to the development of retinopathy of prematurity. S Mohamed K Schaa ME Cooper E Ahrens A Alvarado T Colaizy ML Marazita JC Murray JM Dagle, Pediatr Res 2009 65 193 197 10.1203/PDR.0b013e31818d1dbd 18787502
43. Norrin, frizzled 4 and LRP5 signaling in endothelial cells controls a genetic program for retinal vascularization. X Ye YS Wang H Cahill MZ Yu TC Badea PM Smallwood NS Peachey J Nathans, Cell 2009 139 285 298 10.1016/j.cell.2009.07.047 19837032
44. Moderate reduction of norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy. M Qin H Kondo T Tahira K Hayashi, Hum Genet 2008 122 615 623 10.1007/s00439-007-0438-8 17955262
45. An animal model for Norrie disease: gene targeting of mouse ND gene. W Berger D Van de Pool D Bachner F Oerlemans H Winkens H Hameister B Wieringa W Hendricks H-H Ropers, Hum Mol Genet 1996 5 51 59 10.1093/hmg/5.1.51 8789439
46. Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled- 4 gene. Y Wang D Huso H Cahill D Ruygo J Nathans, J Neurosci 2001 21 4761 4771 11425903
47. A model for familial exudative vitreoretinopathy caused by LRP5 mutations. CH Xia H Liu D Cheung M Wang C Cheng X Du B Chang B Beutler X Gong, Hum Mol Genet 2008 17 1605 1612 10.1093/hmg/ddn047 18263894
48. TSPAN12 regulates retinal vascular development by promoting norrin but not Wnt induced FZD4/beta-catenin signaling. HJ Junge S Yang JR Burton K Paes X Shu DM French M Costa DS Rice W Ye, Cell 2009 139 299 311 10.1016/j.cell.2009. 07.048 19837033
49. A potential biomarker in the cord blood of preterm infants who develop retinopathy of prematurity. A Madan G El-Ferzli SM Carlson JC Whitin J Schilling A Najmi TT Yu K Lau RA Dimmitt HJ Cohen, Pediatr Res 2007 61 215 221 10.1203/pdr.0b013e31802d776d 17237725